AM-Pharma welcomes Mark Altmeyer as Chairman of its Supervisory Board
– NETHERLANDS, Utrecht – AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Mark Altmeyer as Chairman of its Supervisory Board, succeeding Martijn Kleijwegt who will remain a member of the board.…